Exosome Analytics develops technologies for the highly sensitive detection of histological markers on exosomes. Based on these techniques, we have developed a diagnostic platform for early detection of ovarian cancer which, according to pilot tests, is twice more sensitive than the serum CA125 test. We will continue the development of exosome-based liquid biopsies of different cancers and aim to take a leading position in the international market for cancer diagnostic products in the future.

Contact email : elena.khomyakova@exosome-analytics.com